Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CT-7439 by Carrick Therapeutics for Breast Cancer: Likelihood of Approval
CT-7439 is under clinical development by Carrick Therapeutics and currently in Phase I for Breast Cancer. According to GlobalData, Phase...
Data Insights
CT-7439 by Carrick Therapeutics for Solid Tumor: Likelihood of Approval
CT-7439 is under clinical development by Carrick Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...